In a filing, Theravance Biopharma Inc revealed its SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda unloaded Company’s shares for reported $10922.0 on Feb 22 ’24. In the deal valued at $8.71 per share,1,254 shares were sold. As a result of this transaction, Farnum Rhonda now holds 311,733 shares worth roughly $2.96 million.
Then, Farnum Rhonda sold 1,378 shares, generating $14,180 in total proceeds. Upon selling the shares at $10.29, the SVP, COMM & MEDICAL AFFAIRS now owns 331,206 shares.
Before that, GRAHAM RICHARD A sold 2,482 shares. Theravance Biopharma Inc shares valued at $25,366 were divested by the SVP, RESEARCH & DEVELOPMENT at a price of $10.22 per share. As a result of the transaction, GRAHAM RICHARD A now holds 346,839 shares, worth roughly $3.29 million.
Evercore ISI downgraded its Theravance Biopharma Inc [TBPH] rating to an In-line from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including SVB Leerink’s analysts, who began to cover the stock in late May with a ‘”an Outperform”‘ rating. JP Morgan also remained covering TBPH and has increased its forecast on November 05, 2021 with a “Neutral” recommendation from previously “an Underweight” rating. JP Morgan revised its rating on September 15, 2021. It rated TBPH as “an Underweight” which previously was an “an Overweight”.
Price Performance Review of TBPH
On Tuesday, Theravance Biopharma Inc [NASDAQ:TBPH] saw its stock jump 0.11% to $9.48. Over the last five days, the stock has gained 4.18%. Theravance Biopharma Inc shares have fallen nearly -15.66% since the year began. Nevertheless, the stocks have fallen -13.11% over the past one year. While a 52-week high of $12.03 was reached on 01/04/24, a 52-week low of $8.21 was recorded on 02/08/24. SMA at 50 days reached $8.95, while 200 days put it at $9.67. A total of 0.51 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For TBPH Stock
The 24-hour chart illustrates a support level at 9.31, which if violated will result in even more drops to 9.14. On the upside, there is a resistance level at 9.64. A further resistance level may holdings at 9.80. The Relative Strength Index (RSI) on the 14-day chart is 62.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.31%. Stochastics %K at 89.32% indicates the stock is a selling.
How much short interest is there in Theravance Biopharma Inc?
A steep rise in short interest was recorded in Theravance Biopharma Inc stocks on Mar 15, 2024, dropping by -0.46 million shares to a total of 8.4 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 8.86 million shares. There was a decline of -5.48%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 41.73% of the overall stock float, the days-to-cover ratio (short ratio) fell to 24.61.
